March 15, 2026 — In a significant move to combat the rising incidence of anal cancer, a new toolkit has been launched to support women diagnosed with the disease. This development comes as diagnoses have nearly doubled over the past two decades, with a 75% increase in the rate among women since the 1980s.
Simone Annis, a Canberra-based artist, was blindsided by her diagnosis of anal cancer just before her 50th birthday. Despite being fit and healthy, Annis found herself facing a disease she knew little about, compounded by the stigma and lack of information available online. “There was a lot of shame and stigma, which I actually didn’t feel at all,” she said. “I decided straight away that I was going to be very honest with everyone, my friends and my family, and use the word anal.”
Understanding the Rise in Diagnoses
New diagnoses of anal cancer have surged, with women accounting for more than 60% of cases. The age-standardised rate has increased from 1.8 to 2.2 cases per 100,000 people since 2001. Nine in ten cases are linked to the human papillomavirus (HPV), a common sexually transmitted infection.
Professor Richard Hillman, who leads one of the few specialized clinics in Australia, noted that many patients struggle to disclose their condition due to societal stigma. “There’s a lack of awareness, not just in the general community, but in many healthcare professionals as well,” Hillman stated. “Often, the women feel a little bit abandoned.”
The New Toolkit: Breaking Down Barriers
To address these challenges, Hillman’s team at St Vincent’s in Darlinghurst, in collaboration with researchers from the University of Sydney, has developed a comprehensive toolkit. This resource aims to dispel myths about anal cancer, provide guidance to healthcare professionals, and support women through their diagnosis and treatment journey.
Mary Hayes, a PhD candidate and nurse at St Vincent’s, emphasized the toolkit’s importance. “A lot of these women that we spoke to didn’t tell their family, their friends – they maybe had one person who knew about their diagnosis,” Hayes explained. “It can be very isolating, very lonely.”
Impact of HPV and Vaccination Programs
HPV is often acquired in the cervix through sexual contact, and in some cases, it can transfer to the anus, leading to cancer. The most common symptom is bleeding, often mistaken for less serious conditions like haemorrhoids. While radiotherapy is effective, it can have long-term effects on sexual function and intimacy.
“It’s a really devastating, tough, life-changing disease,” Hillman said. “These poor women need as much help as they can get.”
The national HPV vaccination program has significantly reduced cervical cancer rates, with high immunization coverage among teenagers. This success story provides a model for increasing awareness and early diagnosis of other HPV-related cancers.
Future Directions and Expert Insights
Dr. Suzanne Mahady, a gastroenterologist and clinical epidemiologist at Monash University, highlighted the potential long-term impact of universal HPV vaccinations on reducing anal cancer rates. However, she cautioned that this reduction might take decades to materialize.
Mahady also stressed the importance of open communication with healthcare providers. “People should not be afraid to visit their doctor if they notice unusual symptoms,” she advised, acknowledging the discomfort some patients feel discussing anal and rectal issues.
The toolkit will be distributed across cancer clinics in New South Wales, Victoria, and South Australia, aiming to provide much-needed support and information to women facing this challenging diagnosis. As awareness grows and stigma diminishes, early detection and treatment can improve outcomes for those affected by anal cancer.
